Coleman Mark 4
4 · Axsome Therapeutics, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-19−33,410→ 0 totalExercise: $5.94From: 2015-06-29Exp: 2025-06-29→ Common Stock (33,410 underlying) - Exercise/Conversion
Common Stock
2024-11-19$5.94/sh+33,410$198,455→ 48,010 total
Holdings
- 403,856(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Represents the exercise of stock options prior to expiration for cash and hold of underlying shares.
- [F2]Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.